N Malignancy (%) Operative time (min) EBL (mL) LOS (days) Overall morbidity (%) 30-day mortality (%) R0 resection (%) Lymph node harvest (mean) Author Lap Open Lap Open Lap…
MDACC AHPBA/SSO/SSAT NCCN Celiac axis (CA) No extension Clear fat plane around CA No contact Common hepatic artery (CHA) No extension Clear fat plane around CHA No contact Superior…
Fig. 15.1 (a, b) Coronal CT images of anatomic variations of the IMV insertion site. In Fig. 15.1a, the IMV drains into the SMV (Arrow) whereas in Fig. 15.1b, the…
Author Premalignant lesion n Treatment Median area of ablation, mm (range) Outcome Complications Gan, et al. Cystic tumors of the pancreas 25 EUS-guided ethanol lavage 19.4 (6–30) Complete resolution in…
AHPBA/SSAT/SSO MD Anderson NCCN 2012a Intergroup trial SMV-PV Abutmentb, encasementc, or occlusion Occlusion Abutment with impingement or narrowing Interface between tumor and vessel measuring 180° or greater of the…
Author Year N Technical success (%) Morbidity (%) Mortality (%) Recurrence (%) Stent Surgery Stent Surgery Stent Surgery Stent Surgery Bornman et al. 1986 50 84 76 28 32 8…
Fig. 8.1 Computed tomography scan of a locally advanced tumor (a) prior to chemotherapy and (b) following chemotherapy and SBRT to 33 Gy in 5 fractions. Patient then underwent a…
Fig. 11.1 Computed tomography scan of patient with BRPC due to hepatic arterial involvement both before (a) and after (b) neoadjuvant therapy with FOLFIRINOX. The tumor can be seen encasing…
Response criteria Groups Definition Advantages Disadvantages References Radiologic RECIST Complete response Disappearance – Objective, well-evaluated response measure in solid tumors – Not well established in BRCP and LAPC [12] Partial…
Reference BRPC cases Regiment Number resected (%) R0 resection (%) OS, all pts (mo) OS, resected pts (mo) Turrini [85] 49 5-FU/Cis + XRT 9 b b b Chun [24] 74 5-FU/Gem + XRT…
